Abstract
This paper is a first look of Covid-19’s effect on the alpha and beta of a US stock exchange traded fund. It uses the efficient market hypothesis and the J-test of non-nested hypotheses to identify a reasonable choice of Covid-19 data for estimating CAPM regressions. Obtained through the generalized method of moments in a panel data analysis, a reasonable choice is Covid-19 spread’s unanticipated severity. Rising unanticipated severity significantly reduces the alphas and betas of mid-cap and small-cap ETFs but not large-cap and sector & speciality ETFs. Hence, retail investors should not market time or panic liquidate, especially when successful vaccination development is likely in the near future.
Original language | English |
---|---|
Pages (from-to) | 123-128 |
Number of pages | 6 |
Journal | Applied Economics Letters |
Volume | 29 |
Issue number | 2 |
Early online date | 14 Dec 2020 |
DOIs | |
Publication status | Published - 19 Jan 2022 |
Scopus Subject Areas
- Economics and Econometrics
User-Defined Keywords
- CAPM
- Covid-19
- GMM estimation
- J-test
- stock ETFs